Liposomal dosage form development--some practical considerations.
D000818:Animals; D000967:Antimony Sodium Gluconate / Q000627:therapeutic use*; D002214:Capsules; D003362:Cost-Benefit Analysis; D004355:Drug Stability; D004356:Drug Storage; D005942:Gluconates / Q000627:therapeutic use*; D006801:Humans; D007263:Infusions, Parenteral / Q000191:economics; D007898:Leishmaniasis, Visceral / Q000188:drug therapy* / Q000191:economics; D008081:Liposomes / Q000008:administration & dosage* / Q000032:analysis; D051379:Mice; D008854:Microscopy, Electron; D012157:Mononuclear Phagocyte System / Q000187:drug effects
D002214:Capsules; D005942:Gluconates; D008081:Liposomes; D000967:Antimony Sodium Gluconate